Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2758-2762
Published online before print October 12, 2006, doi: 10.1161/01.ATV.0000249638.01416.4b
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/12/2758    most recent
01.ATV.0000249638.01416.4bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nilsson, P. M.
Right arrow Articles by Flyvbjerg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nilsson, P. M.
Right arrow Articles by Flyvbjerg, A.
Related Collections
Right arrow Epidemiology
Right arrow Risk Factors
Right arrow Doppler ultrasound, Transcranial Doppler etc.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2758.)
© 2006 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Plasma Adiponectin Levels in Relation to Carotid Intima Media Thickness and Markers of Insulin Resistance

Peter M. Nilsson; Gunnar Engström; Bo Hedblad; Jan Frystyk; Margaretha M. Persson; Göran Berglund; Allan Flyvbjerg

From Department of Clinical Sciences Medicine (P.M.N., G.E., B.H., G.B.), University Hospital, University of Lund, Malmö, Sweden; Clinical Research Unit Medicine (P.M.N., M.M.P., G.B.), University Hospital, Malmö, Sweden; Epidemiological Research Group (B.H.), University Hospital, Malmö; and Medical Research Laboratories (J.F., A.F.), Clinical Institute and Medical Department M (Diabetes and Endocrinology), Aarhus University Hospital, Aarhus, Denmark.

Correspondence to Peter M. Nilsson, MD, PhD, Department of Clinical Sciences Medicine, University Hospital, S-205 02 Malmö, Sweden. E-mail Peter.Nilsson{at}med.lu.se

Background— Circulating adiponectin is a marker for insulin sensitivity, derived from fat cells. It is largely unknown if adiponectin is also an independent marker for early atherosclerosis.

Methods and Results— Plasma adiponectin levels were measured in 373 men and 514 women of middle-age by a time-resolved immunofluorometric assay. The subjects were sampled stratified for degree of insulin sensitivity (HOMA-IR). An ultrasound measurement of the right common carotid artery intima media thickness (IMT) was made. When the distribution of adiponectin was stratified into sex-specific quartiles (Q1 to Q4), men in Q4 differed from Q1 in higher mean age and high-density lipoprotein (HDL) cholesterol, but lower blood pressure, HbA1c, HOMA-index, and body mass index. Women showed similar associations. Mean IMT for men was significantly lower (P=0.03) in adiponectin Q4 as compared with Q1 when adjusted for age, waist, smoking, HDL cholesterol, and diastolic blood pressure. When adding HbA1c and HOMA to the model, the association was no longer significant (P=0.15). In women no difference in IMT was noticed across adiponectin quartiles.

Conclusion— Plasma adiponectin is a marker of glucose metabolism and obesity and shows an inverse age-adjusted association with carotid ultrasound IMT in men, but not in women. This association is attenuated after adjustments for other risk factors.

Plasma adiponectin is a marker of glucose metabolism and obesity and shows an inverse age-adjusted association with carotid ultrasound IMT in men, but not in women, selected for varying degree of insulin resistance (HOMA) in a population-based study (n=887). This association is attenuated after adjustment for metabolic risk factors.


Key Words: adiponectin • atherosclerosis • glucose • IMT • insulin • obesity




This article has been cited by other articles:


Home page
Eur Heart JHome page
P. M. Nilsson
Is adiponectin and its genetic regulators useful or not for prediction of carotid intima-media thickness and coronary heart disease?
Eur. Heart J., February 1, 2008; 29(3): 293 - 295.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Femia, M. Kozakova, M. Nannipieri, C. Gonzales-Villalpando, M. P. Stern, S. M. Haffner, and E. Ferrannini
Carotid Intima-Media Thickness in Confirmed Prehypertensive Subjects: Predictors and Progression
Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2244 - 2249.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Tsioufis, K. Dimitriadis, M. Selima, C. Thomopoulos, C. Mihas, I. Skiadas, D. Tousoulis, C. Stefanadis, and I. Kallikazaros
Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients
Eur. Heart J., May 1, 2007; 28(9): 1162 - 1169.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Wiecek, M. Adamczak, and J. Chudek
Adiponectin--an adipokine with unique metabolic properties
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 981 - 988.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
R. P F Dullaart, R. de Vries, A. van Tol, and W. J Sluiter
Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender
Eur. J. Endocrinol., March 1, 2007; 156(3): 387 - 394.
[Abstract] [Full Text] [PDF]